Skip to Main Content

Urszula Masiukiewicz, MD

Senior Director, Global Clinical Research and Development

Contact Information

Urszula Masiukiewicz, MD

Appointments

Biography

Dr. Urszula Masiukiewicz is an Assistant Clinical Professor of Medicine at Yale School of Medicine and an attending physician at Yale New-Haven Hospital. She obtained her medical degree from Warsaw Medical School, Warsaw, Poland, and completed postgraduate training at the National Institute of Cardiology in Warsaw, Poland and internal medicine residency at the University of Massachusetts-Memorial Medical Center, Worcester, Massachusetts. In 1996 Dr. Masiukiewicz joined Yale University as a fellow in endocrinology and rose to the rank of Assistant Professor. Dr. Masiukiewicz is a Senior Director in Cardiovascular and Metabolic Division at Pfizer, where she has conducted clinical research since 2004. Dr. Masiukiewicz is a part time clinical faculty member at Yale University and has clinical interests in postmenopausal osteoporosis, disorders of calcium metabolism, metabolic bone disease and thyroid disease.

Education & Training

  • Fellow Hartford/NIA Center of Excellence
    Yale University School of Medicine (2000)
  • Fellow
    Yale University School of Medicine (1999)
  • Chief Medical Resident
    UMass Memorial Medical Center (1996)
  • Resident
    Medical Center of Central Massachusetts (1995)
  • Externship Residency
    UConn, New Britain General Hospital (1993)
  • Resident
    National Institute of Cardiology (1988)
  • MD
    Warsaw University (1985)

Activities

  • Temporal Effects of Teriparatide on Bone Microarchitecture Assessed by High Resolution Peripheral Quantitative Computerized Tomography and Paired Bone Biopsies in Postmenopausal Women with Osteoporosis
    Denver, CO, United States 2009
    Temporal Effects of Teriparatide on Bone Microarchitecture Assessed by High Resolution Peripheral Quantitative Computerized Tomography and Paired Bone Biopsies in Postmenopausal Women with Osteoporosis
  • . Temporal Changes in Bone Strength During 12 Months of Treatment with Teriparatide in Post-Menopausal Women with Osteoporosis
    Denver, CO, United States 2009
    . Temporal Changes in Bone Strength During 12 Months of Treatment with Teriparatide in Post-Menopausal Women with Osteoporosis

Honors & Recognition

AwardAwarding OrganizationDate
Young Investigator AwardAmerican Society for Bone and Mineral Research2000
Clinical Scientist AwardNIH NIDDK1998
Endocrine Fellows Foundation Research AwardEndocrine Fellows Foundation1998
Hartford/NIA Center of Excellence in AgingYale Research1998

Departments & Organizations